Hints and tips:
...Analysing people’s spit might seem a pretty shaky launchpad to the pharmaceutical greatness 23andMe is hoping will rescue its fortunes....
...No mention of the B-word, then....
...Like peers Purdue Pharma and Mallinckrodt, Endo believes the power of the bankruptcy process to funnel opioid litigation into a single, binding forum is the cleanest way to resolve its liability....
...Kingfisher also ranked among the top payers, offering store workers at its B&Q retail chain a 9.8 per cent pay rise after increases in April and December....
...However, GSK said its vaccine candidate proved highly effective across both the A and B strains. GSK also used its adjuvant to boost efficacy, which Pfizer did not use....
...Five years ago, Wall Street investors could barely hide their enthusiasm for up-and-coming pharmaceutical companies like Mallinckrodt. It was not just the science that got them excited....
...Mene Pangalos, executive vice-president of biopharmaceutical R&D at AstraZeneca, conceded that mRNA vaccines “probably have a 4-6 week advantage” for this reason....
...But now pharmaceutical companies are preparing to do it all over again....
...The US Drug Enforcement Administration once labelled Mallinckrodt plc the “kingpin of the drug cartel” for its massive market share of opioid pill production....
...Big consumer companies will look at brands offering “a specific consumer proposition” rather than generic compounds such as vitamins A, B and C, said Mr Ackerman....
...According to the Interfaith Center on Corporate Responsibility (ICCR), a similar resolution filed at pharmaceutical group Mallinckrodt was withdrawn in March after the company decided to divest its opioid...
...The problem in Germany was “a failure to implement the B&M offer, rather than a rejection of it,” it argued....
...The US Federal Trade Commission announced the settlement with Mallinckrodt ARD, formerly known as Questcor, and parent company Mallinckrodt plc....
..., media, pharmaceuticals and telecoms — weakened....
...Prices of bonds issued by a number of the companies that have been accused of overpricing — including Valeant Pharmaceuticals, Endo International and Mallinckrodt — have fallen sharply, pushing up yields...
...Scandalised by the actions of Turing Pharmaceuticals, which had raised the price of a drug for Aids sufferers from $13.50 to $750 a pill, she pledged to crack down on “price gouging”....
...Dublin-based Mallinckrodt....
...There is a new pharmaceuticals giant in town....
...Sector peer Hikma Pharmaceuticals bounced 2.5 per cent to £19.33 on reports that it was in the auction to buy Roxane Laboratories, the $2bn-valued generic drugmaker being sold by Boehringer....
...A fourth division, Publicis Healthcare, will cater specifically to the group’s clients in the health and pharmaceuticals industries....
...Earlier this year, Valeant, the Canadian drug group, agreed to buy Salix, a gastrointestinal specialist, for almost $16bn following a bidding war, while Endo and Mallinckrodt have also become serial acquirers...
...Since the start of 2014, the S&P 500 healthcare index has advanced 26 per cent, including gains of more than 100 per cent by Hospira, Mallinckrodt and Allergan — two of which agreed to takeovers — while...
...Among them was Zoetis, the animal health group in which he recently amassed a stake and suggested as a Plan B target....
...of R&D investment large drugmakers should fund....
...The R&D tax credit bill is due for a vote in the House of Representatives on Thursday and is expected to pass the lower chamber of Congress....
International Edition